Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response

Area of Science:

• Oncology
• Medical Imaging
• Immunotherapy

Background:

• Immunotherapy has revolutionized cancer treatment, offering improved prognoses for many patients.
• However, a significant portion of patients do not respond to immunotherapy, and the underlying mechanisms remain unclear.
• Noninvasive monitoring is essential for tracking treatment efficacy and identifying non-responders early.

Purpose of the Study:

• To review recent advancements in molecular magnetic resonance imaging (MRI) for monitoring cancer immunotherapy.
• To discuss the physics, computational, and biological aspects of molecular MRI in this context.
• To explore the potential of artificial intelligence (AI) in interpreting molecular MRI data for immunotherapy.

Main Methods:

• Review of recent literature on molecular MRI techniques applied to cancer immunotherapy monitoring.
• Analysis of preclinical and clinical studies evaluating molecular MRI in immunotherapy.
• Discussion of AI-based strategies for image analysis and interpretation.

Main Results:

• Molecular MRI provides a biologically-oriented imaging approach to detect early treatment effects.
• Advanced MRI techniques allow for tailored contrast to highlight specific biophysical properties.
• AI integration shows promise for enhanced quantification and interpretation of molecular MRI data.

Conclusions:

• Molecular MRI is a promising tool for noninvasive monitoring of cancer immunotherapy.
• Further development and integration of AI can optimize the use of molecular MRI for personalized treatment strategies.
• This approach holds potential for earlier detection of treatment response and non-response.